ELEV   $0.61  5.17% Market Closed After Close 0.6299 3.26%

Elevation Oncology Inc
Total Cash 110.85M
totalCashPerShare 1.875
EBITDA -39.66M
Total Debt 30.92M
quickRatio 40.119
currentRatio 41.104
Total Revenue
debtToEquity 38.207
Revenue/Share
ROA -0.22058001
ROE -0.51866
grossProfits
freeCashflow -31.22M
operatingCashflow -43.32M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -46.83M
forwardPE -0.625
floatShares 41.05M
sharesOutstanding 59.11M
sharesShort 5.95M
sharesShortPriorMonth 6.26M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.00%
heldPercentInstitutions 1.02%
Short Ratio help_outline 8.34%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue 1.292
Price To Book help_outline 0.43
earningsQuarterlyGrowth
netIncomeToCommon -39.70M
trailingEps -0.67%
forwardEps -0.88%
enterpriseToEbitda 1.18
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.2 3Q 2024
institutionsCount 107
lastUpdated Nov. 7, 2024, 5:09 a.m.